Intravitreal Infliximab for Proliferative Vitreoretinopathy

NCT04891991 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cairo University